Education
About Us
Working with TipRanks
Follow Us
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
MNPR Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MNPR Stock 12 Month Forecast
Average Price Target
$58.00
▲(43.81% Upside)
| Highest Price Target$76.00 | Average Price Target$58.00 | Lowest Price Target$40.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Piper Sandler
Initiated
03/19/25
H.C. Wainwright
Reiterated
01/22/25
JonesTrading
$9→$37
Buy
-8.26%
Downside
Reiterated
11/19/24
Monopar Therapeutics Gains Buy Rating Following Strategic Agreement and Promising Phase III Results for Wilson's Disease Treatment
Rodman & Renshaw
$50
Buy
23.98%
Upside
Initiated
10/11/24
Monopar Therapeutics initiated with a Buy at Rodman & RenshawMonopar Therapeutics initiated with a Buy at Rodman & Renshaw
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Piper Sandler
Initiated
03/19/25
H.C. Wainwright
Reiterated
01/22/25
JonesTrading
$9→$37
Buy
-8.26%
Downside
Reiterated
11/19/24
Monopar Therapeutics Gains Buy Rating Following Strategic Agreement and Promising Phase III Results for Wilson's Disease Treatment
Rodman & Renshaw
$50
Buy
23.98%
Upside
Initiated
10/11/24
Monopar Therapeutics initiated with a Buy at Rodman & RenshawMonopar Therapeutics initiated with a Buy at Rodman & Renshaw
MNPR Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Jan 25
Mar 25
Strong Buy
4
5
4
4
3
Buy
0
0
1
3
3
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
5
5
7
6
Each month's total comprises the sum of three months' worth of ratings.
MNPR Financial Forecast
MNPR Stock Forecast FAQ
What is MNPR’s average 12-month price target, according to analysts?
Based on analyst ratings, Monopar Therapeutics Inc’s 12-month average price target is $58.00.
What is MNPR’s upside potential, based on the analysts’ average price target?
Monopar Therapeutics Inc has 43.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MNPR a Buy, Sell or Hold?
Monopar Therapeutics Inc has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Monopar Therapeutics Inc’s price target?
The average price target for Monopar Therapeutics Inc is $58.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $76.00 ,the lowest forecast is $40.00. The average price target represents 43.81% Increase from the current price of $40.33.
The highest analyst price target is $76.00 ,the lowest forecast is $40.00. The average price target represents 43.81% Increase from the current price of $40.33.
What do analysts say about Monopar Therapeutics Inc?
Monopar Therapeutics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of MNPR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.